About the Company
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
399
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on ARTIVION, INC.
Artivion Inc. Discloses November 2024 Cyberattack, Raising Concerns of ...
Artivion Inc. is publicly traded on the NYSE under the symbol “AORT.” Artivion Inc. employs more than 1,500 people and generates approximately $368 million in annual revenue.
Earnings Miss: Artivion, Inc. Missed EPS And Analysts Are Revising ...
It's been a mediocre week for Artivion, Inc. (NYSE:AORT) shareholders, with the stock dropping 13% to US$25.42 in the week since its latest full-year results. Things were not great overall, with a ...
Artivion Inc (AORT) Q1 2025 Earnings Report Preview: What To Look For
Artivion Inc (NYSE:AORT) is set to release its Q1 2025 earnings on May 5, 2025. The consensus estimate for Q1 2025 revenue is $94.99 million, and the earnings are expected to come in at -$0.12 per ...
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
Shares of Artivion (AORT) have been strong performers lately, with the stock up 9.8% over the past month. The stock hit a new 52-week high of $25.51 in the previous session. Artivion has gained 32 ...
Artivion (NYSE:AORT shareholders incur further losses as stock ... - Nasdaq
But the last three years have been particularly tough on longer term Artivion, Inc. (NYSE:AORT) shareholders. Regrettably, they have had to cope with a 50% drop in the share price over that period.
6AORT : Deep Dive Into Artivion Stock: Analyst Perspectives (4 Ratings)
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
Artivion, Inc.: Artivion Reports Second Quarter 2025 Financial Results
Achieved revenue of $113.0 million in the second quarter of 2025 versus $98.0 million in the second quarter of 2024, an increase of 15% ...
Should You Invest in Artivion (AORT) for a Long-Term Benefit?
One-month return of Artivion, Inc. (NYSE:AORT) was 3.76%, and its shares lost 29.16% of their value over the last 52 weeks. Artivion, Inc. (NYSE:AORT) has a market capitalization of $523.074 million.
Artivion, Inc. (NYSE:AORT) Shares Sold by Thrivent Financial for ...
Artivion Trading Up 1.3 % NYSE AORT opened at $25.00 on Thursday. Artivion, Inc. has a one year low of $19.36 and a one year high of $32.33. The company has a 50-day simple moving average of $27. ...
Artivion, Inc. (AORT) Q3 2023 Earnings Call Transcript
Artivion, Inc. (NYSE: AORT) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Laine Morgan - Gilmartin Group Pat Mackin - Chairman, President, and Chief Executive ...
Earnings Miss: Artivion, Inc. Missed EPS And Analysts Are Revising ...
It's been a mediocre week for Artivion, Inc. (NYSE:AORT) shareholders, with the stock dropping 13% to US$25.42 in the week since its latest full-year results. Things were not great overall, with a ...
Similar Companies
Loading the latest forecasts...